West Welcomes Robert McMahon as Incoming Chief Financial Officer

Core Insights - West Pharmaceutical Services, Inc. has appointed Robert McMahon as the new Chief Financial Officer (CFO), effective August 4, 2025, succeeding Bernard Birkett who is retiring [1][2] - McMahon has a strong background in the healthcare industry, having served as CFO at Agilent Technologies since 2018 and held executive roles at Hologic and Johnson & Johnson [2][3] - The company generated $2.89 billion in net sales in fiscal year 2024 and is a key player in providing innovative injectable solutions [4] Company Overview - West Pharmaceutical Services, Inc. is a leading provider of high-quality injectable solutions and services, supporting drug developers in the safe delivery of medicines [3] - The company operates over 50 sites globally, including 25 manufacturing facilities, and delivers over 41 billion components and devices annually [3] Leadership Transition - Bernard Birkett will transition to the role of Senior Advisor to the CEO until the end of the year to ensure a smooth handover [1] - McMahon expressed enthusiasm about joining West and contributing to its growth and innovation [3]